Hernandez is a well-respected and proven entrepreneurial leader with extensive experience in company creation, early-stage technology development, with private and public market financing. He has founded or led six entrepreneurial companies in cutting-edge arenas, raising over $150M in investment capital and commercialized respective products. Hernandez has launched and played key roles in paradigm-shifting-technologies such as COX-2 inhibitors, microarrays, Human Papillomavirus (HPV) diagnostics, biological sensors, personalized medicine, and oncology. He possesses a broad knowledge of licensing, operations, marketing, financing, and deal structuring. He is an executive with a strong educational background in biology, medicine, molecular genetics, microbiology, epidemiology, marketing, and finance. Hernandez is an excellent communicator and presenter, with extensive world travels and experience in managing and interacting with diverse cultures, high-level executives and elected officials.